BOSTON — Representatives of some of the nation’s largest generic drug manufacturers used code words to collude with competitors to divvy up market share and coordinate price increases according to a federal lawsuit. In another email, representatives from three companies talk about coordinating “polite f-u” letters in 2014 in response to a congressional probe into price increases in the generic …